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Persistently elevated IgA antibodies to Mycoplasma
pneumoniae in patients with internal carotid artery
stenosis
Persistent erhöhte IgA Antikörper gegen Mycoplasma pneumoniae bei
Patienten mit Stenose der A. carotis interna
Abstract
Background:IthasbeensuggestedthatMycoplasmapneumoniaemay
play a role in the development of atherosclerosis, but to date this asso-
ciation is still a matter of debate due to conflicting findings.
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Methods: We have investigated the levels of specific IgA antibodies to
M.pneumoniaein91patientswithinternalcarotidartery(ICA)stenosis
using a commercial kit (SeroMP™ IgA; Savyon Diagnostics, Israel; cut- Ojan Assadian
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off value: 20 binding units; BU). All patients underwent surgery for ICA
stenosis. From each patient, the first serum sample (S1) was taken
before surgery, and the second after an interval of 6 month (S2). 1 Mödling, Austria
Results: The S1 seroprevalence was 18.7% (17/91). Thirteen of the 17
patients with positive S1 levels also remained positive after six month,
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whereby no decrease of IgA level was seen (median S1 level: 34 BU, Wilhelminenspital Vienna,
Vienna, Austria range: 22–65 BU; median S2 level: 37 BU, range: 22–58 BU). Specific-
ally, six of the patients showed an increased level after 6 months, and 3 Clinical Institute for
LaboratoryMedicine,Medical six a decrease, with the level remaining constant in one patient. In
contrast, only 3 of the 74 S1 negative patients became positive for University Vienna, Vienna
anti-M. pneumoniae IgA between the taking of the first and the second General Hospital, Vienna,
Austria serum specimen (p<0.01). None of the assessed demographic factors
orriskfactorsforatherosclerosiswasassociatedwithIgAseropositivity,
neither were the degree CAVK or the degree of stenosis.
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Conclusion: These findings cannot be explained throughout by the
general seroprevalence, or by past respiratory tract infections with the
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pathogen, and therefore may suggest a role for M. pneumoniae in the
development of atherosclerosis, since a chronic infection must be as-
sumed.
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Zusammenfassung
Hintergrund:MycoplasmapneumoniaewurdemitderPathogeneseder
Arteriosklerose in Verbindung gebracht. Bis heute konnte dieser mög-
liche Zusammenhang jedoch nicht endgültig bestätigt oder verworfen
werden und bleibt daher Gegenstand kontroverser Diskussion.
Methoden: Wir untersuchten den spezifischen IgA Antikörper-Wert von
91 Patienten mit Stenose der A. carotis interna mittels eines kommer-
ziellen Kits (SeroMP™ IgA; Savyon Diagnostics, Israel; cut-off Wert: 20
B.E.). Alle Patienten durchliefen eine gefäßchirurgische Operation der
A. carotis interna. Von jedem Patienten wurden die erste Serumprobe
(S1)vorderOperationundeinezweiteSerumprobe(S2)6Monatenach
der Operation abgenommen.
Ergebnisse: Die S1 Seroprävalenz betrug 18,7% (17/91). 13 der 17
Patienten mit positivem S1 IgA Wert blieben auch 6 Monaten nach der
operativen Sanierung der Stenose positiv, wobei kein Abfall der IgA-
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Research Article OPEN ACCESSWerte zu verzeichnen war (Medianer S1 Wert: 34 BU, Range: 22–65
BU; Medianer S2 Wert: 37 BU, Range: 22–58 BU). Sechs dieser Patien-
ten zeigten eine Erhöhung der Werte nach 6 Monaten und 6 weitere
Patienten verstarben. Bei einem Patienten blieben die Werte konstant.
Im Gegenzug dazu wurden nur 3 der 74 S1-negativen Patienten nach
6 Monaten Kontrolle positiv für anti-M. pneumoniae IgA Antikörper
(p<0,01). Keine der untersuchten demographischen Risikofaktoren für
Arteriosklerose, Grad der CAVK oder der Stenose korrelierten mit der
IgA-Seropositivität.
Schlussfolgerungen:DieseErgebnissekönnennichtdurchdieallgemein
hoheDurchseuchungderBevölkerungodervergangenerrespiratorischer
Infektionen mit M. pneumonia erklärt werden, womit eine mögliche
Rolle von M. pneumoniae im Zusammenhang mit der Pathogenese der
Arteriosklerosenichtausgeschlossenwerdenkann,daeinechronische
Infektion vermutet werden muss.
Schlüsselwörter:Mycoplasmapneumonia,IgA,Arteriosklerose,Stenose,
erhöhte Antikörper, A. carotis interna
Introduction
Mycoplasma pneumoniae is an important cause of re-
spiratory tract infections including community-acquired
pneumonia [1]. It has been suggested that the pathogen
may also play a role in the development of atherosclero-
sis. This hypothesis is supported by the ability of
M.pneumoniaetocauseextrapulmonarymanifestations
affecting the blood vessels [2], [3], [4]. Some recent
studies found an association between M. pneumoniae
infectionandatherosclerosis[5],[6],[7].However,others
have presented discordant results, so that the role of
M. pneumoniae in the pathogenesis of atherosclerosis
must still be regarded as unknown [8], [9].
Serum IgA antibodies are a more reliable indicator for
acuteM.pneumoniaeinfectionthanIgM,becausespecif-
ic IgM are not mounted regularly in elderly patients [10],
[11]. Importantly, the serum level of specific IgA declines
to normal values earlier after acute infection than the
level of specific IgM, with a significant decrease 60 days
after the onset of disease [12]. Therefore, persistently
elevated IgA serum levels may indicate chronic infection.
The aim of this study was to investigate the role of
M. pneumoniae in the development atherosclerosis by
repeated testing of specific IgA over a period of 6 month.
Material and methods
Ninety-one consecutive patients with symptomatic and
asymptomaticinternalcarotidartery(ICA)stenosis>70%,
whowereadmittedforsurgeryMarchandJuly2004were
enrolled in this study. Fifty-three patients were male and
38 were female. The age ranged from 41 to 86 years
(median: 69 years). Thirty-nine patients (43%) had
asymptomatic ICA stenosis, 32 patients (35%) had tran-
sient ischaemic episodes and 20 patients (22%) were
operated on for non-disabling stroke.
All patients were planned for routine eversion endarter-
ectomy (EEA) of the ICA under regional anaesthesia. As
anaestheticagent1%lidocainewasusedforacombined
superficialanddeepcervicalblock.Symptomaticpatients
with stroke had an interval of less than 6 weeks prior to
surgery;symptomaticpatientswithtransienthemispheric
and non-hemispheric symptoms were all operated on
within 3 weeks after presentation. For all patients, the
following data were assessed: Age, sex, clinical stage of
carotidarterydisease(CAD)(right/left),degreeofstenosis
(right/left), body mass index (BMI), alcohol consumption
(gram/week),nicotine(cigarettes/day),diabetesmellitus,
cholesterol, triglycerides and homocysteine.
Patients on antihypertensive medication or a blood
pressure of ≥140/75 mmHg on repeat measurements
were characterized hypertensive.
MaximumICAstenosiswasassessedbymagneticreson-
anceangiographyandDuplexandstenosisof≥70%were
an indication for surgery.
Serum was obtained by venipuncture of the antecubital
vein using standard tubes (Vacuette EDTA Tubes, Greiner
Bio-One, Kremsmuenster, Austria) and centrifugation 10
minutes at 2,000 G. Serum was stored at –80°C until
use. The first serum specimen (S1) was taken before
surgery, and the second after an interval of 6 months
(S2). Specific IgA were measured by the SeroMP™ IgA kit
(Savyon Diagnostics, Ashdod, Israel) according to the
manufacturer’s recommendations. As indicated by the
manufacturer values >20 BU (Binding Units) were con-
sidered positive.
Allpatientsgavewritteninformedconsent.Thestudywas
approved by the local ethics committee.
Statistical analysis was performed by Chi squared test
(Yates correction), using EpiInfo 2002™ (CDC, Atlanta,
GA, USA). A p-value of <0.05 was considered significant.
Results
TheIgAseroprevalenceatadmission(S1)was18.7%(17
of 91 patients). In these patients, the median S1 value
was 35 BU (range: 22–58 BU). Thirteen of these 17 pa-
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Daxböck et al.: Persistently elevated IgA antibodies to Mycoplasma ...Table 1: Results of IgA ELISA and clinical data in 18 patients who were tested positive (>20 binding units; BU) on at least one
occasion
tients were also tested positive for anti-M. pneumoniae
IgA after a period of 6 month (median: 36 BU; range:
22–57 BU). Among the 74 patients with negative S1
results, only 3 showed a positive result after 6 months
(p<0.01). The ELISA results and basic clinical data of the
18 patients with ≥1 result >20 BU are shown by Table 1.
Noneoftheassesseddemographicfactorsorriskfactors
foratherosclerosiswasassociatedwithIgAseropositivity,
neither were the degree CAVK or the degree of stenosis.
Discussion
In this study we found a considerable seroprevalence of
IgAantibodiestoM.pneumoniaeinpatientswithinternal
carotid artery stenosis. However, the more remarkable
finding was that in the majority of our patients IgA re-
mained elevated at essentially constant levels through a
period of at least 6 month. In contrast, few patients (3)
developedspecificIgAbetweenthetakingofthefirstand
the second serum specimen.
We have focused on IgA determination in the present
study, because specific IgM formation may be lacking in
theelderly[10].IgGantibodies,ontheotherhand,remain
elevated for longtime after infection, which results in a
high IgG seroprevalence, that can cause interpretation
difficulties [1].
Determination of specific IgA is a suitable tool for the
diagnosis of M. pneumoniae infection [11]. It has been
shown that after infection specific IgA decline to normal
values (i.e. levels below the cut-off value of commercially
available tests) earlier than specific IgM [12]. However,
IgA-based diagnosis is less established than IgM- or IgG-
baseddiagnosis,andpersistentlyelevatedIgAasindicator
of chronic infection, although biologically plausible, has
to be interpreted with caution. It has to be mentioned
that differing figures concerning the seroprevalence of
IgAantibodiestoM.pneumoniaeinelderlypatientshave
beenpublished,withseroprevalencesupto79%[8],[13].
However, the applied assay and the respective cut-off
level for positivity is obviously important in this context.
By the assay applied in the present study, we have found
a seroprevalence of 13% (>20 BU) and no value >30 BU
among 46 healthy subjects [11].
A certain variance of ELISA results has to be considered.
Nevertheless,asignificanttrendtoadecreaseinantibody
level would be expected if the elevated IgA levels in our
patientsshouldsimplyreflectpastrespiratorytractinfec-
tion. It is notable that in the 13 patients with persistently
high IgA levels, 6 showed an increasing and 6 a decreas-
ing IgA level, with the level in one patient remaining con-
stant (Table 1).
An important study negotiating a potential role of
M. pneumoniae in the development of atherosclerosis
has been provided by Maraha et al., who failed to detect
the pathogen in the great majority of 103 atherectomy
specimens and degenerative heart valve specimens [9].
However,itshouldbeconsideredthatsomemycoplasma-
associated diseases, including severe pneumonia and
neurological manifestations, are immunologically medi-
ated and require the presence of the pathogen only in an
early stage of the disease [14], [15], [16]. Therefore,
serologicalmethodsmaybeadvantageoustoexplorethe
association between M. pneumoniae infection and ath-
erosclerosis.
In conclusion, we have applied a new serological ap-
proach to investigate the role of M. pneumoniae in the
development of atherosclerosis. The results can not be
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by past respiratory tract infections with the pathogen, so
that they suggest a role for M. pneumoniae in the devel-
opment of atherosclerosis. However, it has to be con-
sideredthattheassociationbetweenchronicmycoplasma
infection and persistently elevated IgA antibodies is not
yet proven by large-scale epidemiological investigations.
Future studies on the potential role of M. pneumoniae in
the development of atherosclerosis are warranted.
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